Medical Director, Noninvasive Cardiology Services, Cardio-Pulmonary Lab and Respiratory Care, Baylor Scott and White Hospital - Brenham, Texas;
Cardiology
Dr. Pierre Zoldhelyi, MD
|
|
Give Review
Pierre Zoldhelyi practices Cardiology. He studied medicine at University of Padua College of Medicine. He received awards:"Fellow (FACC)". Doctor Pierre Zoldhelyi, MD has written publications. He has 31 publications published with PubMed. The lastest paper is: 'Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs.' He accepts Medicare.
Publications
- CD34/M-cadherin Bone Marrow Progenitor Cells Promote Arteriogenesis in Ischemic Hindlimbs of ApoE Mice.
- Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs.
- Gene transfer of COX-1 improves lumen size and blood flow in Carotid bypass grafts.
- Local gene transduction of cyclooxygenase-1 increases blood flow in injured atherosclerotic rabbit arteries.
- Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration.
- E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1.
- Effect of hirudin vs heparin on haemostatic activity in patients with Acute coronary syndromes; the GUSTO-IIb haemostasis substudy.
- Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries.
- [New antithrombotic therapy approaches in coronary Heart disease--prospects for gene therapy].
- Growth suppression of human Coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F-1.
- Inhibition of Coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor.
- Thromboresistance of balloon-injured porcine Carotid arteries after local gene transfer of human tissue factor pathway inhibitor.
- The emerging clinical potential of cardiovascular gene therapy.
- Future directions in thrombolysis.
- Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after Coronary angioplasty in pigs.
- Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats.
- Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces Acute hypoxic pulmonary vasoconstriction in rats.
- Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
- Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene.
- Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig.
- Recombinant hirudin in patients with chronic, stable Coronary artery disease. Safety, half-life, and effect on coagulation parameters.
- Gene therapy for vascular Diseases.
- Persistent thrombin generation in humans during specific thrombin inhibition with hirudin.
- Restoration of prostacyclin synthesis by transfer of prostaglandin H synthase cDNA.
- Novel antithrombotic drugs in development.
- Gene therapy to restore prostacyclin presence to injured endothelium.
- Plaque disruption and thrombosis in unstable Angina pectoris.
- Role of thrombin in arterial thrombosis: implications for therapy.
- Pathogenesis of thrombosis in unstable Angina.
- Antithrombotic therapy and progression of Coronary artery disease. Antiplatelet versus antithrombins.
Schools
University Of Padua
Montefiore Med CtrAlbert Einstein Coll Of Medicine
Mayo Clinic
Procedures Preformed
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioversion, Elective
- Chest CT (incl. Heart and Lungs)
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Internal Medicine
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Mayo School of Graduate Medical Education -
Albert Einstein - Montefiore Medical Center -
University of Padua College of Medicine
Hospital
-
Scott & White Memorial Hospital
Drug Facts
| NPI NUMBER | 1689607616 | |
| NPPES Provider LastName | ZOLDHELYI | |
| NPPES Provider FirstName | PIERRE | |
| NPPES Provider ZIPCode | 770962714 | |
| NPPES Provider State | TX | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2517.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1689607616 |
| Last Name Of The Provider | ZOLDHELYI |
| First Name Of The Provider | PIERRE |
| View All |
Similar Doctors
|
Dr. Kenneth Landgraf, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Weldon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francisco A. Leal Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William R. Loesch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bobby W. Marek, MD
This Doctor is OpenDoctor Recommended.
|